vandetanib

epidermal growth factor receptor ; Homo sapiens







155 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
151 15367698 ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. 2004 Sep 3
152 15596048 Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models. 2004 Dec 10
153 15604279 Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. 2004 Dec 15 6
154 15623642 ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity. 2004 Dec 15 2
155 12684431 Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 2003 Apr 7